Visceral fat loss may be tied to lasting metabolic benefits, even when body weight returns. Digest
Many weight-loss efforts focus on the number on the scale, but long-term metabolic health may also depend on where fat is lost. A new study examined whether losing visceral fat, the fat stored around abdominal organs, was linked to lasting metabolic health after structured lifestyle programs.
You just missed this in your inbox
Every other week our Premium Members received this exact study plus Rhonda's practical commentary and 8+ other hand-picked papers.
The analysis included 381 adults with excess abdominal fat or abnormal blood lipid levels from two earlier 18-month randomized diet and physical activity trials. Long-term follow-up data were available for 366 participants. Of these, 325 returned for in-person assessments conducted 5 years after one trial and 10 years after the other trial ended. The original programs compared several dietary strategies, including Mediterranean-style approaches, and incorporated structured physical activity. Researchers used magnetic resonance imaging (MRI) scans to measure visceral fat, subcutaneous fat (fat beneath the skin), and fat in the liver and pancreas. They also measured waist size, body weight, blood markers of metabolic health, and tracked new diagnoses of type 2 diabetes through health records. These assessments also included markers of insulin resistance, which reflects how well the body responds to insulin, and metabolic syndrome severity, which combines risk factors such as excess waist size, high blood pressure, elevated blood sugar, high triglycerides, and low high-density lipoprotein (HDL) cholesterol.
- Weight returned, but waist size stayed slightly lower. Average body weight fell from about 202 to 195 pounds during the intervention and returned to about 202 pounds over the next 5 to 10 years. Waist size fell from about 42.4 to 40.3 inches and was still about 40.7 inches years later.
- Abdominal and subcutaneous fat remained lower despite weight regain. The deeper layer of subcutaneous fat decreased from 242.1 to 185.1 cm² during the intervention and measured 211.5 cm² years later. The more superficial layer fell from 132.2 to 106.1 cm² and later measured 117.6 cm², while visceral fat declined from 148.6 to 109.0 cm² and was 124.8 cm² at the long-term follow-up. Liver and pancreas fat did not stay reduced.
- Reductions in visceral fat during the intervention were linked to more favorable markers of insulin resistance and metabolic syndrome severity.
- Only visceral fat loss showed a clear diabetes risk signal. Among participants without type 2 diabetes by the end of the trials, each 10% reduction in visceral fat during the interventions was linked to a 28% lower risk of developing type 2 diabetes during follow-up.
Visceral fat is not just passive storage. When this fat depot expands, it can become more metabolically active and inflammatory. This can increase the release of fatty acids and chemical signals that can reach the liver and other organs where they interfere with the body's response to insulin. In the liver, this can weaken insulin's normal ability to restrain glucose output while also favoring greater fat production, fat release into the bloodstream, and fat storage within the liver. These shifts are closely tied to insulin resistance, abnormal blood lipids, metabolic syndrome, and diabetes. For that reason, reducing visceral fat may improve metabolic health in ways that changes in body weight alone can miss.
A key limitation is that this long-term analysis was observational, so it cannot prove that visceral fat loss itself caused the lower diabetes risk. The cohort was also more than 90% male, which limits how confidently the findings apply to women. Even so, the results suggest that some benefits of lifestyle programs may persist through changes in fat distribution even when body weight returns. In Aliquot #147, I explain how to break the visceral fat cycle.